Olaplex (OLPX) Projected to Post Quarterly Earnings on Thursday

Key Points

• Olaplex will report Q1 2026 results before the market opens on May 14 at 9:00 AM ET; analysts expect $0.01 EPS and about $94.1M in revenue.
• Insiders have sold a total of 215,442 shares worth roughly $271,457 over the past 90 days (insiders now own 4.30%), including notable March sales by Trisha L. Fox and CFO Catherine Dunleavy.
• Shares opened at $2.04 (52‑week range $0.99–$2.04) with a $1.37B market cap, and the consensus analyst rating is Hold with an average target price of $1.92.

Olaplex (NASDAQ:OLPX - Get Free Report) is anticipated to issue its Q1 2026 results before the market opens on Thursday, May 14th. Analysts expect the company to announce earnings of $0.01 per share and revenue of $94.1140 million for the quarter. Parties may review the information on the company's upcoming Q1 2026 earning report for the latest details on the call scheduled for Thursday, May 14, 2026 at 9:00 AM ET.

Olaplex (NASDAQ:OLPX - Get Free Report) last announced its earnings results on Thursday, March 5th. The company reported $0.01 EPS for the quarter, hitting the consensus estimate of $0.01. The company had revenue of $105.12 million for the quarter, compared to analysts' expectations of $104.21 million. Olaplex had a positive return on equity of 1.07% and a negative net margin of 2.19%.The business's revenue for the quarter was up 4.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.01 earnings per share. On average, analysts expect Olaplex to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Olaplex Price Performance

Shares of OLPX stock opened at $2.04 on Thursday. The stock's fifty day moving average is $1.75 and its 200-day moving average is $1.48. The company has a debt-to-equity ratio of 0.40, a quick ratio of 4.00 and a current ratio of 4.58. The stock has a market capitalization of $1.37 billion, a PE ratio of -204.00 and a beta of 1.87. Olaplex has a 52 week low of $0.99 and a 52 week high of $2.04.

Insider Activity at Olaplex

In related news, insider Trisha L. Fox sold 26,426 shares of the firm's stock in a transaction dated Monday, March 9th. The stock was sold at an average price of $1.26, for a total value of $33,296.76. Following the transaction, the insider owned 721,169 shares in the company, valued at $908,672.94. This trade represents a 3.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO Catherine Dunleavy sold 93,809 shares of the firm's stock in a transaction dated Thursday, March 12th. The stock was sold at an average price of $1.26, for a total value of $118,199.34. Following the transaction, the chief financial officer owned 3,026,885 shares in the company, valued at approximately $3,813,875.10. This trade represents a 3.01% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 215,442 shares of company stock worth $271,457 over the last 90 days. Insiders own 4.30% of the company's stock.

Hedge Funds Weigh In On Olaplex

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OLPX. Bank of Montreal Can bought a new position in shares of Olaplex during the 4th quarter valued at about $57,000. Picton Mahoney Asset Management bought a new position in shares of Olaplex during the 4th quarter valued at about $193,000. CANADA LIFE ASSURANCE Co lifted its holdings in shares of Olaplex by 2,320.4% during the 3rd quarter. CANADA LIFE ASSURANCE Co now owns 135,639 shares of the company's stock valued at $180,000 after purchasing an additional 130,035 shares in the last quarter. Intech Investment Management LLC lifted its holdings in shares of Olaplex by 15.8% during the 3rd quarter. Intech Investment Management LLC now owns 74,780 shares of the company's stock valued at $98,000 after purchasing an additional 10,192 shares in the last quarter. Finally, Sei Investments Co. bought a new position in shares of Olaplex during the 2nd quarter valued at about $160,000. Institutional investors own 87.37% of the company's stock.

Analyst Ratings Changes

OLPX has been the topic of several research analyst reports. Canaccord Genuity Group cut Olaplex from a "strong-buy" rating to a "hold" rating in a report on Thursday, March 26th. Jefferies Financial Group reiterated a "buy" rating on shares of Olaplex in a report on Wednesday, March 4th. Wall Street Zen upgraded Olaplex from a "sell" rating to a "hold" rating in a report on Saturday, March 7th. Northland Securities cut Olaplex from a "strong-buy" rating to a "hold" rating in a report on Thursday, March 26th. Finally, Morgan Stanley set a $1.40 price target on Olaplex in a report on Tuesday, March 10th. One equities research analyst has rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $1.92.

Olaplex Company Profile

Olaplex, Inc NASDAQ: OLPX is a specialty haircare company known for its patented bond-building technology designed to repair and strengthen hair from within. The company’s core offerings encompass a range of professional salon treatments and at-home maintenance products that target chemical damage, breakage and split ends. Olaplex formulations are built around a proprietary active ingredient that works at the molecular level to rebuild disulfide bonds broken during bleaching, coloring and heat styling processes.

Founded in 2014 and headquartered in Irvine, California, Olaplex initially gained traction among high-end salons before expanding into broader retail channels.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.